Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Supportive care in cancer 2001-05, Vol.9 (3), p.209-210
Hauptverfasser: Krupova, Y, Mistrik, M, Bojtarova, E, Sejnova, D, Ilavska, I, Krcmery, Jr, V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 210
container_issue 3
container_start_page 209
container_title Supportive care in cancer
container_volume 9
creator Krupova, Y
Mistrik, M
Bojtarova, E
Sejnova, D
Ilavska, I
Krcmery, Jr, V
description
doi_str_mv 10.1007/s005200000194
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s005200000194</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11401107</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-935762464a29d4b71c9eb79bc89b001bbabd31b7e205d403b042dd557fcf209a3</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxYMotlaPXiVHPUTz2ZijFr9g0YN68LQk2axd2d2EJBV68H83pQVxLjMwP97MewCcEnxJMJZXCWNB8aaI4ntgSjhjSDKm9sEUK04QZ0JMwFFKXwWRUtBDMCGEY0KwnIKfqgs--UH3cFynrHM3wvMKPX-8XsAy5qWLOqyhb2FY9YMfdVxDnYKLn13f-9QlGF0btc2-LLKH1o_fbsxdIXuoh7D02cXOFqnbjZ7Vo3URhnKnUOkYHLS6T-5k12fg_f7ubfGIqpeHp8VNhSy9VhkpJuSc8jnXVDXcSGKVM1IZe61MMWWMNg0jRjqKRcMxM5jTphFCtralWGk2A2ira6NPqXxch9gNxUtNcL2Jsf4XY-HPtnxYmcE1f_QuN_YLLndvRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Krupova, Y ; Mistrik, M ; Bojtarova, E ; Sejnova, D ; Ilavska, I ; Krcmery, Jr, V</creator><creatorcontrib>Krupova, Y ; Mistrik, M ; Bojtarova, E ; Sejnova, D ; Ilavska, I ; Krcmery, Jr, V</creatorcontrib><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s005200000194</identifier><identifier>PMID: 11401107</identifier><language>eng</language><publisher>Germany</publisher><subject>Adolescent ; Adult ; Amphotericin B - therapeutic use ; Antifungal Agents - administration &amp; dosage ; Antifungal Agents - adverse effects ; Antifungal Agents - therapeutic use ; Aspergillosis - drug therapy ; Child ; Female ; Fluconazole - therapeutic use ; Humans ; Liposomes ; Lung Diseases, Fungal - drug therapy ; Male ; Middle Aged ; Neoplasms - complications ; Nystatin - administration &amp; dosage ; Nystatin - adverse effects ; Treatment Failure ; Treatment Outcome</subject><ispartof>Supportive care in cancer, 2001-05, Vol.9 (3), p.209-210</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-935762464a29d4b71c9eb79bc89b001bbabd31b7e205d403b042dd557fcf209a3</citedby><cites>FETCH-LOGICAL-c289t-935762464a29d4b71c9eb79bc89b001bbabd31b7e205d403b042dd557fcf209a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11401107$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krupova, Y</creatorcontrib><creatorcontrib>Mistrik, M</creatorcontrib><creatorcontrib>Bojtarova, E</creatorcontrib><creatorcontrib>Sejnova, D</creatorcontrib><creatorcontrib>Ilavska, I</creatorcontrib><creatorcontrib>Krcmery, Jr, V</creatorcontrib><title>Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Amphotericin B - therapeutic use</subject><subject>Antifungal Agents - administration &amp; dosage</subject><subject>Antifungal Agents - adverse effects</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aspergillosis - drug therapy</subject><subject>Child</subject><subject>Female</subject><subject>Fluconazole - therapeutic use</subject><subject>Humans</subject><subject>Liposomes</subject><subject>Lung Diseases, Fungal - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasms - complications</subject><subject>Nystatin - administration &amp; dosage</subject><subject>Nystatin - adverse effects</subject><subject>Treatment Failure</subject><subject>Treatment Outcome</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1LAzEQxYMotlaPXiVHPUTz2ZijFr9g0YN68LQk2axd2d2EJBV68H83pQVxLjMwP97MewCcEnxJMJZXCWNB8aaI4ntgSjhjSDKm9sEUK04QZ0JMwFFKXwWRUtBDMCGEY0KwnIKfqgs--UH3cFynrHM3wvMKPX-8XsAy5qWLOqyhb2FY9YMfdVxDnYKLn13f-9QlGF0btc2-LLKH1o_fbsxdIXuoh7D02cXOFqnbjZ7Vo3URhnKnUOkYHLS6T-5k12fg_f7ubfGIqpeHp8VNhSy9VhkpJuSc8jnXVDXcSGKVM1IZe61MMWWMNg0jRjqKRcMxM5jTphFCtralWGk2A2ira6NPqXxch9gNxUtNcL2Jsf4XY-HPtnxYmcE1f_QuN_YLLndvRQ</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Krupova, Y</creator><creator>Mistrik, M</creator><creator>Bojtarova, E</creator><creator>Sejnova, D</creator><creator>Ilavska, I</creator><creator>Krcmery, Jr, V</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200105</creationdate><title>Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients</title><author>Krupova, Y ; Mistrik, M ; Bojtarova, E ; Sejnova, D ; Ilavska, I ; Krcmery, Jr, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-935762464a29d4b71c9eb79bc89b001bbabd31b7e205d403b042dd557fcf209a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Amphotericin B - therapeutic use</topic><topic>Antifungal Agents - administration &amp; dosage</topic><topic>Antifungal Agents - adverse effects</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aspergillosis - drug therapy</topic><topic>Child</topic><topic>Female</topic><topic>Fluconazole - therapeutic use</topic><topic>Humans</topic><topic>Liposomes</topic><topic>Lung Diseases, Fungal - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasms - complications</topic><topic>Nystatin - administration &amp; dosage</topic><topic>Nystatin - adverse effects</topic><topic>Treatment Failure</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krupova, Y</creatorcontrib><creatorcontrib>Mistrik, M</creatorcontrib><creatorcontrib>Bojtarova, E</creatorcontrib><creatorcontrib>Sejnova, D</creatorcontrib><creatorcontrib>Ilavska, I</creatorcontrib><creatorcontrib>Krcmery, Jr, V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krupova, Y</au><au>Mistrik, M</au><au>Bojtarova, E</au><au>Sejnova, D</au><au>Ilavska, I</au><au>Krcmery, Jr, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients</atitle><jtitle>Supportive care in cancer</jtitle><addtitle>Support Care Cancer</addtitle><date>2001-05</date><risdate>2001</risdate><volume>9</volume><issue>3</issue><spage>209</spage><epage>210</epage><pages>209-210</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><cop>Germany</cop><pmid>11401107</pmid><doi>10.1007/s005200000194</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0941-4355
ispartof Supportive care in cancer, 2001-05, Vol.9 (3), p.209-210
issn 0941-4355
1433-7339
language eng
recordid cdi_crossref_primary_10_1007_s005200000194
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Adult
Amphotericin B - therapeutic use
Antifungal Agents - administration & dosage
Antifungal Agents - adverse effects
Antifungal Agents - therapeutic use
Aspergillosis - drug therapy
Child
Female
Fluconazole - therapeutic use
Humans
Liposomes
Lung Diseases, Fungal - drug therapy
Male
Middle Aged
Neoplasms - complications
Nystatin - administration & dosage
Nystatin - adverse effects
Treatment Failure
Treatment Outcome
title Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liposomal%20nystatin%20(L-NYS)%20in%20therapy%20of%20pulmonary%20aspergillosis%20refractory%20to%20conventional%20amphotericin%20B%20in%20cancer%20patients&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Krupova,%20Y&rft.date=2001-05&rft.volume=9&rft.issue=3&rft.spage=209&rft.epage=210&rft.pages=209-210&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s005200000194&rft_dat=%3Cpubmed_cross%3E11401107%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11401107&rfr_iscdi=true